Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

User-centered design of multi-gene sequencing panel reports for clinicians.

Cutting E, Banchero M, Beitelshees AL, Cimino JJ, Fiol GD, Gurses AP, Hoffman MA, Jeng LJ, Kawamoto K, Kelemen M, Pincus HA, Shuldiner AR, Williams MS, Pollin TI, Overby CL.

J Biomed Inform. 2016 Oct;63:1-10. doi: 10.1016/j.jbi.2016.07.014. Epub 2016 Jul 14.

2.

Integrating Genomic Resources with Electronic Health Records using the HL7 Infobutton Standard.

Heale BS, Overby CL, Del Fiol G, Rubinstein WS, Maglott DR, Nelson TH, Milosavljevic A, Martin CL, Goehringer SR, Freimuth R, Williams MS.

Appl Clin Inform. 2016 Aug 31;7(3):817-31. doi: 10.4338/ACI-2016-04-RA-0058.

3.

Practical considerations in genomic decision support: The eMERGE experience.

Herr TM, Bielinski SJ, Bottinger E, Brautbar A, Brilliant M, Chute CG, Cobb BL, Denny JC, Hakonarson H, Hartzler AL, Hripcsak G, Kannry J, Kohane IS, Kullo IJ, Lin S, Manzi S, Marsolo K, Overby CL, Pathak J, Peissig P, Pulley J, Ralston J, Rasmussen L, Roden DM, Tromp G, Uphoff T, Weng C, Wolf W, Williams MS, Starren J.

J Pathol Inform. 2015 Sep 28;6:50. doi: 10.4103/2153-3539.165999. eCollection 2015.

4.

Prioritizing Approaches to Engage Community Members and Build Trust in Biobanks: A Survey of Attitudes and Opinions of Adults within Outpatient Practices at the University of Maryland.

Overby CL, Maloney KA, Alestock TD, Chavez J, Berman D, Sharaf RM, Fitzgerald T, Kim EY, Palmer K, Shuldiner AR, Mitchell BD.

J Pers Med. 2015 Jul 28;5(3):264-79. doi: 10.3390/jpm5030264.

5.

Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians.

Overby CL, Devine EB, Abernethy N, McCune JS, Tarczy-Hornoch P.

J Biomed Inform. 2015 Jun;55:249-59. doi: 10.1016/j.jbi.2015.04.011. Epub 2015 May 7.

6.

Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support.

Overby CL, Erwin AL, Abul-Husn NS, Ellis SB, Scott SA, Obeng AO, Kannry JL, Hripcsak G, Bottinger EP, Gottesman O.

J Pers Med. 2014 Feb 27;4(1):35-49. doi: 10.3390/jpm4010035.

7.
8.

Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.

Shuldiner AR, Palmer K, Pakyz RE, Alestock TD, Maloney KA, O'Neill C, Bhatty S, Schub J, Overby CL, Horenstein RB, Pollin TI, Kelemen MD, Beitelshees AL, Robinson SW, Blitzer MG, McArdle PF, Brown L, Jeng LJ, Zhao RY, Ambulos N, Vesely MR.

Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):76-84. doi: 10.1002/ajmg.c.31396. Epub 2014 Mar 10.

9.

Cancer genetic counselor information needs for risk communication: a qualitative evaluation of interview transcripts.

Overby CL, Chung WK, Hripcsak G, Kukafka R.

J Pers Med. 2013;3(3). doi: 10.3390/jpm3030238.

10.

Evaluation considerations for EHR-based phenotyping algorithms: A case study for drug-induced liver injury.

Overby CL, Weng C, Haerian K, Perotte A, Friedman C, Hripcsak G.

AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:130-4. eCollection 2013.

11.

Opportunities for genomic clinical decision support interventions.

Overby CL, Kohane I, Kannry JL, Williams MS, Starren J, Bottinger E, Gottesman O, Denny JC, Weng C, Tarczy-Hornoch P, Hripcsak G.

Genet Med. 2013 Oct;15(10):817-23. doi: 10.1038/gim.2013.128. Epub 2013 Sep 19. No abstract available.

12.

Personalized medicine: challenges and opportunities for translational bioinformatics.

Overby CL, Tarczy-Hornoch P.

Per Med. 2013 Jul 1;10(5):453-462.

13.

A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury.

Overby CL, Pathak J, Gottesman O, Haerian K, Perotte A, Murphy S, Bruce K, Johnson S, Talwalkar J, Shen Y, Ellis S, Kullo I, Chute C, Friedman C, Bottinger E, Hripcsak G, Weng C.

J Am Med Inform Assoc. 2013 Dec;20(e2):e243-52. doi: 10.1136/amiajnl-2013-001930. Epub 2013 Jul 9.

14.

Developing a prototype system for integrating pharmacogenomics findings into clinical practice.

Overby CL, Tarczy-Hornoch P, Kalet IJ, Thummel KE, Smith JW, Del Fiol G, Fenstermacher D, Devine EB.

J Pers Med. 2012 Nov 20;2(4):241-56. doi: 10.3390/jpm2040241.

15.

Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions.

Overby CL, Devine EB, Tarczy-Hornoch P, Kalet IJ.

J Am Med Inform Assoc. 2012 Sep-Oct;19(5):840-50. doi: 10.1136/amiajnl-2011-000405. Epub 2012 Apr 26.

16.

e-PKGene: a knowledge-based research tool for analysing the impact of genetics on drug exposure.

Hachad H, Overby CL, Argon S, Yeung CK, Ragueneau-Majlessi I, Levy RH.

Hum Genomics. 2011 Jul;5(5):506-15. Review.

17.

Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.

Overby CL, Tarczy-Hornoch P, Hoath JI, Kalet IJ, Veenstra DL.

BMC Bioinformatics. 2010 Oct 28;11 Suppl 9:S10. doi: 10.1186/1471-2105-11-S9-S10.

18.

The potential for automated question answering in the context of genomic medicine: an assessment of existing resources and properties of answers.

Overby CL, Tarczy-Hornoch P, Demner-Fushman D.

BMC Bioinformatics. 2009 Sep 17;10 Suppl 9:S8. doi: 10.1186/1471-2105-10-S9-S8.

19.

Supplemental Content

Loading ...
Support Center